SpringWorks Therapeutics, Inc. (SWTX)

SpringWorks Therapeutics Revenue

SpringWorks Therapeutics had revenue of $49.09M in the quarter ending March 31, 2025, with 133.68% growth. This brings the company's revenue in the last twelve months to $219.67M, up 730.42% year-over-year. In the year 2024, SpringWorks Therapeutics had annual revenue of $191.59M with 3,417.33% growth.

• Revenue (ttm): $219.67M
• Revenue Growth: +730.42%
• P/S Ratio: 15.62
• Revenue / Employee: $596,929
• Employees: 368
• Market Cap: 3.47B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	191.59M	186.14M	3,417.33%
Dec 31, 2023	5.45M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	35.00M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.